Opko Health Inc. (NYSE:OPK) CEO Phillip Md Et Al Frost bought 5,400 shares of the company’s stock in a transaction on Thursday, October 13th. The shares were acquired at an average price of $9.52 per share, for a total transaction of $51,408.00. Following the completion of the acquisition, the chief executive officer now owns 3,068,951 shares in the company, valued at $29,216,413.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Phillip Md Et Al Frost also recently made the following trade(s):

  • On Tuesday, October 11th, Phillip Md Et Al Frost bought 7,200 shares of Opko Health stock. The shares were acquired at an average price of $9.78 per share, for a total transaction of $70,416.00.
  • On Monday, October 10th, Phillip Md Et Al Frost bought 24,800 shares of Opko Health stock. The shares were acquired at an average price of $9.82 per share, for a total transaction of $243,536.00.
  • On Thursday, October 6th, Phillip Md Et Al Frost bought 4,200 shares of Opko Health stock. The shares were acquired at an average price of $10.53 per share, for a total transaction of $44,226.00.
  • On Tuesday, October 4th, Phillip Md Et Al Frost bought 3,600 shares of Opko Health stock. The shares were acquired at an average price of $10.57 per share, for a total transaction of $38,052.00.
  • On Friday, September 30th, Phillip Md Et Al Frost bought 1,800 shares of Opko Health stock. The shares were acquired at an average price of $10.54 per share, for a total transaction of $18,972.00.
  • On Thursday, September 29th, Phillip Md Et Al Frost bought 3,600 shares of Opko Health stock. The shares were acquired at an average price of $10.67 per share, for a total transaction of $38,412.00.
  • On Wednesday, September 28th, Phillip Md Et Al Frost purchased 5,400 shares of Opko Health stock. The stock was purchased at an average price of $11.01 per share, for a total transaction of $59,454.00.
  • On Tuesday, September 27th, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The stock was purchased at an average price of $11.16 per share, for a total transaction of $20,088.00.
  • On Monday, September 26th, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The stock was purchased at an average price of $11.04 per share, for a total transaction of $19,872.00.
  • On Friday, September 23rd, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The stock was purchased at an average price of $10.95 per share, for a total transaction of $19,710.00.

Opko Health Inc. (NYSE:OPK) opened at 9.45 on Monday. The firm’s 50-day moving average is $10.08 and its 200-day moving average is $10.07. The stock has a market capitalization of $5.20 billion and a price-to-earnings ratio of 39.54. Opko Health Inc. has a 52-week low of $7.12 and a 52-week high of $11.85.

Opko Health (NYSE:OPK) last issued its quarterly earnings results on Monday, August 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.03) by $0.05. The business had revenue of $357.10 million for the quarter, compared to analysts’ expectations of $324.11 million. The firm’s revenue for the quarter was up 742.2% on a year-over-year basis. During the same quarter last year, the company earned ($0.09) earnings per share. Analysts predict that Opko Health Inc. will post ($0.05) earnings per share for the current year.

Insider Buying and Selling by Quarter for Opko Health (NYSE:OPK)

Hedge funds have recently modified their holdings of the company. ProShare Advisors LLC acquired a new stake in shares of Opko Health during the second quarter worth about $100,000. Financial Architects Inc increased its position in shares of Opko Health by 21.5% in the second quarter. Financial Architects Inc now owns 10,950 shares of the company’s stock worth $102,000 after buying an additional 1,940 shares in the last quarter. First Citizens Bank & Trust Co. bought a new position in shares of Opko Health during the second quarter worth approximately $103,000. Williams Jones & Associates LLC increased its position in shares of Opko Health by 352.0% in the second quarter. Williams Jones & Associates LLC now owns 11,300 shares of the company’s stock worth $106,000 after buying an additional 8,800 shares in the last quarter. Finally, Nuveen Fund Advisors LLC bought a new position in shares of Opko Health during the second quarter worth approximately $131,000.

A number of analysts have recently weighed in on the stock. Oppenheimer Holdings Inc. restated a “market perform” rating on shares of Opko Health in a report on Thursday, August 11th. Zacks Investment Research cut shares of Opko Health from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Jefferies Group restated a “hold” rating and issued a $10.00 price target on shares of Opko Health in a report on Monday, October 10th. Standpoint Research raised their price target on shares of Opko Health from $16.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, June 21st. Finally, JPMorgan Chase & Co. set a $14.00 price objective on shares of Opko Health and gave the company a “buy” rating in a research report on Tuesday, August 9th. Five analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $13.20.

About Opko Health

OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.

5 Day Chart for NYSE:OPK

Receive News & Stock Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related stocks with our FREE daily email newsletter.